Rachid Rafia
Novartis (United Kingdom)(GB)
Publications by Year
Research Areas
Health Systems, Economic Evaluations, Quality of Life, Breast Cancer Treatment Studies, Substance Abuse Treatment and Outcomes, Lipoproteins and Cardiovascular Health, Chronic Myeloid Leukemia Treatments
Most-Cited Works
- → Estimated effect of alcohol pricing policies on health and health economic outcomes in England: an epidemiological model(2010)259 cited
- → Sepsis: the LightCycler SeptiFast Test MGRADE®, SepsiTest™ and IRIDICA BAC BSI assay for rapidly identifying bloodstream bacteria and fungi – a systematic review and economic evaluation(2016)133 cited
- → Gene expression profiling and expanded immunohistochemistry tests to guide the use of adjuvant chemotherapy in breast cancer management: a systematic review and cost-effectiveness analysis(2013)105 cited
- → Modelling the Cost-Effectiveness of Alcohol Screening and Brief Interventions in Primary Care in England(2012)84 cited
- → Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer: a systematic review and economic analysis(2019)80 cited
- → The Sheffield Alcohol Policy Model - A Mathematical Description(2014)59 cited
- Healthcare costs and productivity losses directly attributable to ankylosing spondylitis.(2012)
- → Autologous haematopoietic stem cell transplantation for secondary progressive multiple sclerosis: an exploratory cost-effectiveness analysis(2009)46 cited
- → Cost-effectiveness analysis of adding a quadrivalent HPV vaccine to the cervical cancer screening programme in Switzerland(2008)46 cited
- → Estimation of health care costs as a function of disease severity in people with psoriatic arthritis in the UK(2010)45 cited